{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:35:03Z","timestamp":1791232503353,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jcf.2013.03.005","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T16:53:50Z","timestamp":1366649630000},"page":"309-317","source":"Crossref","is-referenced-by-count":75,"title":["A review of renal disease in cystic fibrosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Dilip","family":"Nazareth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Walshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2013.03.005_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2006030269","article-title":"Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney","volume":"18","author":"Jouret","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0010","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-011-1843-8","article-title":"Human nephron number: implications for health and disease","volume":"26","author":"Bertram","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/01.pec.0000245170.31343.bb","article-title":"Hyponatremic dehydration as a presentation of cystic fibrosis","volume":"22","author":"Ballestero","year":"2006","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jcf.2013.03.005_bb0020","series-title":"Annual data report 2010","author":"Cystic Fibrosis Foundation Patient Registry","year":"2011"},{"key":"10.1016\/j.jcf.2013.03.005_bb0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","article-title":"Risk factors for chronic kidney disease in adults with cystic fibrosis","volume":"184","author":"Quon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.1990.182","article-title":"Measurement of renal function in chronic renal disease","volume":"38","author":"Levey","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcf.2013.03.005_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004872-199917030-00002","article-title":"How to assess glomerular function and damage in humans","volume":"17","author":"Rahn","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcf.2013.03.005_bb0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2013.03.005_bb0045","first-page":"F85","article-title":"Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation","volume":"241","author":"Hostetter","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-141-12-200412210-00009","article-title":"Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease","volume":"141","author":"Rule","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jcf.2013.03.005_bb0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.200109-012CC","article-title":"Aminoglycoside prescribing and surveillance in cystic fibrosis","volume":"167","author":"Tan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0065","first-page":"237","article-title":"Accuracy of formula-derived creatinine clearance in paraplegic subjects","volume":"47","author":"Thakur","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0070","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ki.1996.109","article-title":"Early detection and the course of glomerular injury in patients with sickle cell anemia","volume":"49","author":"Guasch","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcf.2013.03.005_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0148607199023004233","article-title":"Effects of Pseudomonas colonization on body composition and resting energy expenditure in children with cystic fibrosis","volume":"23","author":"Vinton","year":"1999","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jcf.2013.03.005_bb0080","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1164\/rccm.200303-363OC","article-title":"Muscle function and resting energy expenditure in female athletes with cystic fibrosis","volume":"168","author":"Selvadurai","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2006.05.004","article-title":"Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients","volume":"6","author":"Al-Aloul","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000182065","article-title":"Aminoglycoside nephrotoxicity and its predictability","volume":"27","author":"Sethi","year":"1981","journal-title":"Nephron"},{"key":"10.1016\/j.jcf.2013.03.005_bb0095","first-page":"230","article-title":"Urinary enzymes. Characterization and diagnostic use","volume":"124","author":"Mondorf","year":"1982","journal-title":"MMW Munch Med Wochenschr"},{"key":"10.1016\/j.jcf.2013.03.005_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-4453(80)90626-X","article-title":"Co-trimoxazole, creatinine and renal function","volume":"2","author":"Trollfors","year":"1980","journal-title":"J Infect"},{"key":"10.1016\/j.jcf.2013.03.005_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF02429057","article-title":"Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy","volume":"145","author":"Steinkamp","year":"1986","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2013.03.005_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2006.05.013","article-title":"Measurement of urinary N-acetyl-b-d-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics","volume":"6","author":"Etherington","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000102085","article-title":"Emerging biomarkers of acute kidney injury","volume":"156","author":"Devarajan","year":"2007","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcf.2013.03.005_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00365510802150158","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease","volume":"241","author":"Devarajan","year":"2008","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.jcf.2013.03.005_bb0130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jcp.24267","article-title":"Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells?","volume":"228","author":"Lim","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1258\/0004563021901847","volume":"39","author":"Newman","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jcf.2013.03.005_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcf.2008.07.004","article-title":"GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis","volume":"8","author":"Beringer","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2710.2008.00932.x","article-title":"Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin","volume":"33","author":"Halacova","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jcf.2013.03.005_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcf.2009.12.002","article-title":"What is the best method for measuring renal function in adults and children with cystic fibrosis?","volume":"9","author":"Soulsby","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00003088-198713040-00002","article-title":"Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance","volume":"13","author":"de Groot","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcf.2013.03.005_bb0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","article-title":"Aminoglycosides: activity and resistance","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcf.2013.03.005_bb0165","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","article-title":"An overview of drug-induced acute kidney injury","volume":"36","author":"Pannu","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00045391-199603000-00011","article-title":"Aminoglycoside-induced nephrotoxicity in cystic fibrosis: a case presentation and review of the literature","volume":"3","author":"Samaniego-Picota","year":"1996","journal-title":"Am J Ther"},{"key":"10.1016\/j.jcf.2013.03.005_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ppul.20138","article-title":"Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use","volume":"39","author":"Al-Aloul","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0180","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1569-1993(12)60163-5","article-title":"Assessment of renal function in cystic fibrosis patients by estimated and measured glomerular filtration rate \u2014 a cross-sectional study","volume":"11","author":"Jain","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1699-0463.1994.tb05219.x","article-title":"Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center","volume":"102","author":"Ciofu","year":"1994","journal-title":"APMIS"},{"key":"10.1016\/j.jcf.2013.03.005_bb0190","first-page":"CD002767","article-title":"Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis","volume":"7","author":"Breen","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2013.03.005_bb0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/thorax.55.5.355","article-title":"Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs","volume":"55","author":"Elborn","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2013.03.005_bb0200","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.2009.131532","article-title":"Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis","volume":"65","author":"Prayle","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2013.03.005_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2010.09.003","article-title":"Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis","volume":"10","author":"Adeboyeku","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s15010-009-8117-4","article-title":"Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.jcf.2013.03.005_bb0215","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis \u2014 the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2013.03.005_bb0220","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/adc.78.6.536","article-title":"Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for Pseudomonas exacerbations in cystic fibrosis","volume":"78","author":"Vic","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2013.03.005_bb0225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1440-1754.2006.00944.x","article-title":"Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis","volume":"42","author":"Massie","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jcf.2013.03.005_bb0230","first-page":"522","article-title":"Cystic fibrosis pulmonary guidelines: airway clearance therapies","volume":"54","author":"Flume","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2013.03.005_bb0235","series-title":"Report of the UK Cystic Fibrosis Trust Antibiotic Working Group","author":"Antibiotic treatment for Cystic Fibrosis","year":"2009"},{"issue":"6","key":"10.1016\/j.jcf.2013.03.005_bb0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/adc.78.6.536","article-title":"Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis","volume":"78","author":"Vic","year":"1998","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.jcf.2013.03.005_bb0245","first-page":"P179","article-title":"A randomised cross over trial of TOBI vs IV tobramycin in acute pulmonary exacerbations in CF","volume":"38","author":"Al-Aloul","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ppul.10185","article-title":"Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy","volume":"34","author":"Hoffmann","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0255","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1542-4758.2012.00675.x","article-title":"Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis","volume":"16","author":"Florescu","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1016\/j.jcf.2013.03.005_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin, a new antibiotic produced by strains of Streptomyces","volume":"166","author":"Hendlin","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.jcf.2013.03.005_bb0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02014882","article-title":"Fosfomycin in the treatment of cystic fibrosis","volume":"3","author":"Katznelson","year":"1984","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0270","first-page":"554","article-title":"Serum and lung tissue levels of fosfomycin in humans","volume":"18","author":"Farago","year":"1980","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1569-1993(02)00143-1","article-title":"Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis","volume":"2","author":"Mirakhur","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0280","first-page":"P121","article-title":"Renoprotective effect of fosfomycin in the treatment of multiresistant Pseudomonas aeruginosa in CF","volume":"59","author":"Al-Aloul","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2013.03.005_bb0285","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/thx.2006.067595","article-title":"Survey of acute renal failure in patients with cystic fibrosis in the UK","volume":"62","author":"Bertenshaw","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2013.03.005_bb0290","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5414\/CNP66464","article-title":"Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa","volume":"66","author":"Izquierdo","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcf.2005.05.017","article-title":"Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES)","volume":"4","author":"Al-Aloul","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0025-6196(11)65134-3","article-title":"The aminoglycosides","volume":"74","author":"Edson","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcf.2013.03.005_bb0305","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2010.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report \u2014 2010","volume":"29","author":"Christie","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcf.2013.03.005_bb0310","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","article-title":"Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion","volume":"43","author":"Ruggenenti","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcf.2013.03.005_bb0315","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1523-1755.2005.00472.x","article-title":"Cellular mechanisms of vascular injury mediated by calcineurin inhibitors","volume":"68","author":"Lamas","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcf.2013.03.005_bb0320","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI116440","article-title":"Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles","volume":"91","author":"Lanese","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2013.03.005_bb0325","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1681\/ASN.2007040394","article-title":"Chronic kidney disease after nonrenal solid-organ transplantation","volume":"18","author":"Bloom","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0330","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1681\/ASN.V1051136","article-title":"Renal failure in the recipients of nonrenal solid organ transplants","volume":"10","author":"Wilkinson","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0335","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1600-6143.2008.02342.x","article-title":"Renal histopathological lesions after lung transplantation in patients with cystic fibrosis","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcf.2013.03.005_bb0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1926","article-title":"Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis","volume":"142","author":"Quon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2013.03.005_bb0345","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198808043190502","article-title":"Microscopic nephrocalcinosis in cystic fibrosis","volume":"319","author":"Katz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0355","first-page":"317","article-title":"Cystic fibrosis and calcium oxalate nephrolithiasis","volume":"69","author":"Chidekel","year":"1996","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0360","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s004670050452","article-title":"Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?","volume":"12","author":"Hoppe","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0365","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-5347(01)69068-2","article-title":"Metabolic risk factors for stone formation in patients with cystic fibrosis","volume":"167","author":"Perez-Brayfield","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1651-2227.1993.tb12667.x","article-title":"Nephrolithiasis in cystic fibrosis","volume":"82","author":"Strandvik","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2013.03.005_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00403-7","article-title":"The association of nephrolithiasis with cystic fibrosis","volume":"42","author":"Gibney","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcf.2013.03.005_bb0380","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2005.09.010","article-title":"Amyloidosis in cystic fibrosis: a case series","volume":"5","author":"Mc Laughlin","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2013.03.005_bb0385","first-page":"879","article-title":"Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study","volume":"110","author":"McGlennen","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jcf.2013.03.005_bb0390","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(95)91009-3","article-title":"Colchicine for secondary nephropathic amyloidosis in cystic fibrosis","volume":"345","author":"Kuwertz-Broking","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2013.03.005_bb0395","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0046-8177(84)80187-2","article-title":"Circulating immune complexes and the nephropathy of cystic fibrosis","volume":"15","author":"Davis","year":"1984","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0400","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/adc.66.12.1444","article-title":"Severe nephropathy in three adolescents with cystic fibrosis","volume":"66","author":"Melzi","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2013.03.005_bb0405","first-page":"30","article-title":"IgA nephropathy in cystic fibrosis","volume":"12","author":"Stirati","year":"1999","journal-title":"J Nephrol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0410","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2013.03.005_bb0415","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ppul.1142","article-title":"Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis","volume":"32","author":"Koch","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0420","series-title":"Report of the UK Cystic Fibrosis Trust Diabetes Working Group: management of cystic fibrosis related diabetes mellitus","year":"2004"},{"key":"10.1016\/j.jcf.2013.03.005_bb0425","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2013.03.005_bb0430","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2013.03.005_bb0435","article-title":"Continuous glucose monitoring (CGM) for cystic fibrosis related diabetes (CFRD): sweet success or bitter disappointment?","volume":"47","author":"Dyce","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0440","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ppul.20124","article-title":"Microalbuminuria as a screening tool in cystic fibrosis-related diabetes","volume":"39","author":"Dobson","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2013.03.005_bb0445","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcf.2008.05.008","article-title":"Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)","volume":"7","author":"van den Berg","year":"2008","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199313000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199313000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T16:11:18Z","timestamp":1644855078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199313000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1569199313000416"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2013.03.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}